![]() |
Volumn 9, Issue 3, 2010, Pages 229-231
|
Adjunctive dexamethasone in meningitis: does value depend on clinical setting?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
DEXAMETHASONE;
PLACEBO;
ADJUVANT THERAPY;
BACTERIAL MENINGITIS;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COCHRANE LIBRARY;
CONSCIOUSNESS;
CORTICOSTEROID THERAPY;
DISABILITY;
EVIDENCE BASED MEDICINE;
HEALTH CARE ACCESS;
HEALTH STATUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERGLYCEMIA;
LETTER;
LIFE EXPECTANCY;
LOWEST INCOME GROUP;
MALAWI;
MORTALITY;
MYCOBACTERIUM TUBERCULOSIS;
OUTCOME ASSESSMENT;
PREVALENCE;
PRIORITY JOURNAL;
REGRESSION ANALYSIS;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
VIET NAM;
WESTERN EUROPE;
CLINICAL TRIALS AS TOPIC;
DEXAMETHASONE;
DRUG THERAPY, COMBINATION;
HUMANS;
MENINGITIS, BACTERIAL;
|
EID: 76649093903
PISSN: 14744422
EISSN: None
Source Type: Journal
DOI: 10.1016/S1474-4422(10)70022-3 Document Type: Letter |
Times cited : (13)
|
References (11)
|